Clinical trial
IB1001-303 (levacetylleucine in ataxia-telangiectasia)
NCT06673056
Underlying trial for FDA approval of AQNEURSA in A-T; результаты опубликованы в Lancet Neurology, июль 2026.
No news refers to this card yet.
Scales
Identifiers
- NCT
- NCT06673056
Original sources
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.